Altamira Therapeutics Ltd. (CYTOF): Total Liabilities

Annual figures by period end, from SEC filings.

Not updated since 2020-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

840.7K CHF
As of 2020-12-31
2.11M CHF2018-12-31: 2.11M CHF2019-12-31: 4.4K CHF2020-12-31: 840.7K CHF840.7K CHF
2018-12-31 Total Liabilities (CHF) 2020-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2020-12-31840.7K CHFn/m2021-03-31, Balance as of period end
2019-12-314.4K CHF-99.8%2021-03-31, Balance as of period end
2018-12-312.11M CHFn/a2021-03-31, Balance as of period end